Cortex Laboratories Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 29 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.00 M
- Revenue Growth 129.26%
- Profit Growth 71.22%
- Ebitda -164.36%
- Net Worth -1.34%
- Total Assets -3.74%
About Cortex Laboratories
Cortex Laboratories Private Limited (CLPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 June 1995 and has a history of 29 years and eight months. Its registered office is in Hyderabad, Telangana.
The Corporate was formerly known as Cortex Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹6.00 M.
Nagi Seelam and Seelam Manojkumarreddy serve as directors at the Company.
Company Details
- Location Hyderabad, Telangana
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230TG1995PTC020588
- Company No.
020588
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jun 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Cortex Laboratories?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagi Seelam  | Director | 22-Jun-2024 | Current |
| Seelam Manojkumarreddy | Additional Director | 03-Feb-2020 | Current |
Financial Performance of Cortex Laboratories.
Cortex Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 129.26% increase. The company also saw a substantial improvement in profitability, with a 71.22% increase in profit. The company's net worth dipped by a decrease of 1.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cortex Laboratories?
In 2022, Cortex Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Concord Drugs LimitedNagi Seelam and Seelam Manojkumarreddy are mutual person
Proton Remedies Private LimitedSeelam Manojkumarreddy is a mutual person
- Seelam Laboratories Private Limited
Seelam Manojkumarreddy is a mutual person
- Continental Pellets Pharma Private Limited
Seelam Manojkumarreddy is a mutual person
Charges (Loans)
₹6.00 M
₹0
Charges Breakdown by Lending Institutions
- Lakshmi Vilas Bank Limited : 0.35 Cr
- The Lakxmi Vilas Bank Limited : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jan 2007 | Lakshmi Vilas Bank Limited | ₹3.50 M | Open |
| 21 Jan 2006 | The Lakxmi Vilas Bank Limited | ₹2.50 M | Open |
How Many Employees Work at Cortex Laboratories?
Cortex Laboratories has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cortex Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cortex Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
